Colonial Trust Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$185K Hold
3,051
0.01% 206
2025
Q4
$165K Sell
3,051
-516
-14% -$24.8K 0.01% 212
2025
Q3
$161K Sell
3,567
-594
-14% -$27.7K 0.01% 218
2025
Q2
$193K Sell
4,161
-300
-7% -$14.7K 0.02% 202
2025
Q1
$272K Sell
4,461
-18
-0.4% -$1.05K 0.02% 177
2024
Q4
$253K Sell
4,479
-1,015
-18% -$56.7K 0.02% 178
2024
Q3
$284K Hold
5,494
0.02% 177
2024
Q2
$228K Buy
5,494
+31
+0.6% +$1.39K 0.02% 175
2024
Q1
$296K Sell
5,463
-413
-7% -$21K 0.03% 160
2023
Q4
$301K Sell
5,876
-991
-14% -$52K 0.03% 156
2023
Q3
$399K Sell
6,867
-1,008
-13% -$61.8K 0.05% 147
2023
Q2
$504K Sell
7,875
-1,005
-11% -$67.4K 0.06% 139
2023
Q1
$615K Buy
8,880
+2,979
+50% +$210K 0.07% 131
2022
Q4
$425K Sell
5,901
-674
-10% -$50.8K 0.05% 147
2022
Q3
$467K Buy
6,575
+754
+13% +$54.7K 0.06% 136
2022
Q2
$448K Hold
5,821
0.06% 125
2022
Q1
$425K Hold
5,821
0.05% 145
2021
Q4
$363K Sell
5,821
-873
-13% -$51.2K 0.04% 152
2021
Q3
$396K Sell
6,694
-150
-2% -$9.88K 0.05% 152
2021
Q2
$457K Sell
6,844
-850
-11% -$55.4K 0.06% 145
2021
Q1
$486K Buy
7,694
+18
+0.2% +$1.12K 0.06% 139
2020
Q4
$476K Buy
7,676
+400
+5% +$24.6K 0.07% 127
2020
Q3
$439K Buy
7,276
+800
+12% +$48.1K 0.07% 123
2020
Q2
$381K Buy
6,476
+477
+8% +$28.5K 0.07% 124
2020
Q1
$334K Hold
5,999
0.07% 118
2019
Q4
$385K Hold
5,999
0.06% 123
2019
Q3
$304K Buy
5,999
+351
+6% +$16.5K 0.05% 131
2019
Q2
$256K Hold
5,648
0.05% 145
2019
Q1
$269K Buy
5,648
+575
+11% +$28.6K 0.05% 136
2018
Q4
$264K Sell
5,073
-574
-10% -$30.8K 0.06% 127
2018
Q3
$351K Sell
5,647
-1,797
-24% -$107K 0.07% 128
2018
Q2
$412K Sell
7,444
-584
-7% -$31.5K 0.08% 124
2018
Q1
$508K Sell
8,028
-2,675
-25% -$172K 0.1% 116
2017
Q4
$656K Buy
10,703
+2,974
+38% +$186K 0.1% 114
2017
Q3
$493K Hold
7,729
0.11% 114
2017
Q2
$431K Buy
7,729
+2,282
+42% +$124K 0.1% 118
2017
Q1
$300K Hold
5,447
0.09% 118
2016
Q4
$318K Sell
5,447
-50
-0.9% -$2.73K 0.1% 115
2016
Q3
$296K Buy
5,497
+250
+5% +$16.1K 0.09% 122
2016
Q2
$386K Hold
5,247
0.12% 113
2016
Q1
$335K Hold
5,247
0.11% 118
2015
Q4
$361K Sell
5,247
-75
-1% -$4.96K 0.12% 120
2015
Q3
$315K Buy
5,322
+400
+8% +$25.4K 0.11% 119
2015
Q2
$328K Sell
4,922
-44
-0.9% -$2.9K 0.1% 121
2015
Q1
$320K Buy
4,966
+2,400
+94% +$150K 0.1% 121
2014
Q4
$151K Sell
2,566
-2,281
-47% -$129K 0.06% 131
2014
Q3
$248K Hold
4,847
0.08% 126
2014
Q2
$235K Sell
4,847
-1,250
-21% -$61.6K 0.07% 125
2014
Q1
$317K Hold
6,097
0.1% 115
2013
Q4
$324K Sell
6,097
-105
-2% -$5.35K 0.1% 103
2013
Q3
$287K Hold
6,202
0.1% 101
2013
Q2
$277K Buy
+6,202
New +$269K 0.1% 100

Other funds holding BMY

Colonial Trust Advisors's BMY Position: Q1 2026 in Review

Colonial Trust Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 3,051 shares worth $185K. The position accounts for 0.01% of the portfolio, ranked #206.

Colonial Trust Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $656K in Q4 2017. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Colonial Trust Advisors held 3,051 shares of Bristol-Myers Squibb worth $185K as of Q1 2026.
  • Colonial Trust Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #206 holding.
  • Colonial Trust Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Colonial Trust Advisors's Bristol-Myers Squibb position peaked at $656K in Q4 2017.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.